Dr. Prasenjit Gogoi
M.E.M pgt 3RD YR
Fortis Hospital, Kolkata
Hypertensive
Emergencies
Introduction
 Hypertensive crisis are acute, severe elevations in
blood pressure that may or may not be associated
with target-organ dysfunction.
 Blood pressure > 180/110 mmHg
 Hypertensive emergencies significant
morbidity and potentially fatal target-organ damage
 1-3% of patients with HTN will have HTN emergency
during their lifetime.
Risk factors
 Female sex
 Higher grades of obesity
 Hypertensive or coronary heart disease
 Mental illness
 Non-adherence of anti-hypertensive medications.
Causes
vary nationally, regionally and institutionally
 Intoxications – cocaine, amphetamines, phencyclidine hydrochloride,
stimulant diet supplements
 Non-adherence to antihypertensive regimens
 Withdrawl syndromes – clonidine or beta antagonist
 Drug-drug/drug-food interactions
 Spinal cord disorders
 Pheochromocytoma
 Pregnancy
 Collagen vascular disease
Acute Target-Organ Damage and Clinical Manifestations
Neurologic
Cerebral infarction
Hypertensive encephalopathy
ICH or SAH
Cardiovascular
Acute pulmonary edema (LVF)
Acute congestive failure (left/right ventricular failure)
Acute coronary ischaemia (MI or unstable angina)
Renal
Acute kidney injury/failure
Liver
Liver enzymes elevations (HELLP syndrome)
Ocular
Retinal hemorrhage/exudate
Vascular
Eclampsia
Aortic dissection
BP Treatment goals for
Hypertensive Emergency
Goal Time BP Target
First hour Reduce MAP by 25% (maintain goal DBP>100mmHg)
Hours 2-6 SBP 160 mmHg and/or DBP 100-110 mmHg
Hours 6-24 Maintain goals for hours 2-6 during first 24 hrs
24-48 hrs Outpatient BP goals according to the 2017 Guidelines
for Management of High BP in adults.
Treatment Goals
 Acute Aortic Dissection
 Medical management should be considered first line
for most non-life threatening type B aortic
dissection.
 Goal heart rate – 60 beats/min within minutes of
presentation.
 Goal Blood Pressure – SBP < 120 mmHg and/or as
low as clnically tolerated.
Treatment Goals
 Acute Ischemic Stroke
 Adaptive response to maintain CPP to the brain.
 Current Guidelines for BP reduction
 Use of thrombolytic therapy
 Other target organ damage ( aortic dissection, MI )
 Severe elevated blood pressure SBP>220 mmHg &
DBP>110 mmHg
 For thrombolytic therapy initiation BP goal is less than
185/110 mmHg
During therapy and subsequent 24 hrs BP goal is
<180/105 mmHg
 Other circumstances – BP goal is 15% (10-20%)
reduction in MAP to allow maintainence of CPP
Treatment Goals
 Acute Hemorrhagic Stroke
 Recent evidences suggest elevated BP during
acute ICH are associated with hematoma
expansion, neurologic deterioration and death.
 BP goal – SBP < 160 mmHg over the first few
hours is relatively safe.
 ATACH-2 trial, patients were randomised with
SBP target of < 140 mmHg or 140-180 mmHg
acutely after ICH hypertensive emergency.
Functional outcome did not differ.
Acute Hypertensive Definations in
the Pregnant Patient
Name BP Criteria Additional Criteria
“Severe” acute
hypertension
SBP > 160 mmHg or
DBP > 110 mmHg
Preeclampsia SBP > 140 mmHg or
DBP > 90 mmHg
BP readings must occur on
>2 occasions, > 4 hrs apart
> 20 weeks gestation
Either :
Proteinuria
Severe features
Eclampsia Same as above New-onset grand mal
seizures in a woman with
no known seizure disorder
HELLP syndrome With or without
preeclampsia degree of BP
elevation
Evidence of the following
Hemolysis
Elevated lover enzymes
Low platelet
Hypertensive emergency BP > 240/140 mmHg
Treatment Goals
 Treatment goals differ in pregnant patients
compared with general hypertensive crisis.
 BP goal for Preeclampsia <160/110 mmHg –
avoid abrupt decrease in blood pressure.
 MAP should be decreased by 20-25% over the
first few minutes to hours and blood pressure
further decreased to the target of 160/110 mmHg
or less over the subsequent hours.
Treatment of Hypertensive
Emergency
 No drug of choice.
 Choice of medication depends on a risk-benefit
analysis of each agent considering the.
 Affected target organ on presentation
 Pharmacokinetics & pharmacodynamics
 Hemodynamic, adverse effect and BPV profile of
the medication profile.
 Extreme caution should be used with acute and
profound lowering of BP Ischaemic
complications.
Medications
Agent Dosing range Onset Duration
Vasodilators
Hydralazine IV Bolus: 10-20 mg
IM : 10-40 mg q30 min
PRN
IV: 10 mins
IM: 20 mins
IV: 1-4 hours
IM: 2-6 hours
Nitroglycerine IV 5-200 mcg/min
Titrate by 5-25
mcg/min q5-10 mins
2-5 mins 5-10 mins
Sodium
nitroprusside
IV 0.25-10 mcg/kg/min
Titrate by 0.1-0.2
mcg/min q5min
seconds 1-2 mins
CCB
Clevidipine IV 1-6 mg/hr
Titrate by 1-2 mg/hr
q90s; max 32 mg/hr
1-4 min 5-15 min
Nicardipine IV 5-15 mg/hr
Titrate by 2.5 mg/hr
q5-10 min
5-10 min 2-6 hours
Agent Dosing range Onset Duration
Beta Blockers
Esmolol IV 25-300 mcg/kg/min
Titrate by 25 mcg/kg/min
q3-5 mins
1-2 mins 10-20 mins
Labetalol IV bolus: 20 mg; may repeat
doses of 20-80 mg q5-10
mins PRN
IV 0.5-10 mg/min
Titrate by 1-2 mg/min q2hr.
2-5 min; peak 5-15
mins
2-6 hr
Upto 18 hr
Metoprolol IV bolus: 5-15 mg q5-15
min PRN
5-20 min 2-6 hr
ACEI
Enalaprilat IV bolus: 1.25 mg q6hr
Titrate no more than q12-24
hr:
Max dose : 5 mg q6hr
15-30 min 12-24 hr
a-Antagonist
Phentolamine IV bolus: 1-5 mg PRN; Max
15 mg
Seconds 15 min
D1 Receptor Agonist
Indications and Special Considerations for
Medications Used for Hypertensive Emergency
Medication Indications Special Considerations
Hydralazine Pregnancy Prolonged hypotension
Risk of reflex tachycardia
Headaches, lupus like
syndrome
Nitroglycerin Coronary ischaemia or infarction
Acute LVF
Pulmonary edema
Tachyphylaxis
Flushing, headache, erythema
Venous greater than arterial
dilator
Sodium nitroprusside Most indications (excluding ICP
elevations and coronary
infarction/ischaemia)
Liver failure – cyanide
accumulation
Renal failure – thiocyanate
accumulation
Toxicity with prolonged
infusion
Increases ICP
Clevidipine Acute ischaemia or hemorrhagic Soy or egg allergy
Medication Indications Special Considerations
Esmolol Aortic dissection
Coronary
ischaemia/infarction
Contraindicated in acute
decompensated heart failure
Useful in tachyarrhythmias
Labetalol Acute ischaemic or hg stroke
Aortic dissection
Coronary
ischaemia/infarction
Pregnancy
Monotherapy in acute aortic
dissection
Contraindicated in acute
decompensated heart failure
Prolonged hypotension
Metoprolol Aortic dissection
Coronary
ischaemia/infarction
Contraindicated in acute
decompensated heart failure
Use in conjunction with arterial
vasodilator
Useful in tachyarrhythmias
Enalaprilat Acute LVF Contraindicated in pregnancy
Prolonged duration of action
Phentolamine Cetecholamine excess
e.g. pheochromocytoma
Use in catecholamine-inducd
HTN er
Used for cocaine induced HTN
crisis with BZDs
Fenoldopam Most indications Caution with increased ICP or
IOP
Practice points
• Determine the presence or absence of target-
organ damage.
• Assessment
• Screen for exceptions – stroke, pregnancy
induced acute htn, aortic dissection- target goal
development.
• In general hypertensive emergencies the goal in
the first 60 mins of treatment is reduce the MAP
by25%.
• Patient with exceptions have unique treatment
goals leading to unique medication selection.
• Goal of medication selection is to provide
References
 American college of cardiology – 2017 guideline
for detection, evaluation and management of high
blood pressure in adults.
 American college of clinical pharmacology –
ccsap2018 – hypertensive emergencies.
 American college of obs&gynae (ACOG) – task
force for htn in pregnancy.
THANK YOU..!!

Hypertensive emergencies

  • 1.
    Dr. Prasenjit Gogoi M.E.Mpgt 3RD YR Fortis Hospital, Kolkata Hypertensive Emergencies
  • 2.
    Introduction  Hypertensive crisisare acute, severe elevations in blood pressure that may or may not be associated with target-organ dysfunction.  Blood pressure > 180/110 mmHg  Hypertensive emergencies significant morbidity and potentially fatal target-organ damage  1-3% of patients with HTN will have HTN emergency during their lifetime.
  • 4.
    Risk factors  Femalesex  Higher grades of obesity  Hypertensive or coronary heart disease  Mental illness  Non-adherence of anti-hypertensive medications.
  • 7.
    Causes vary nationally, regionallyand institutionally  Intoxications – cocaine, amphetamines, phencyclidine hydrochloride, stimulant diet supplements  Non-adherence to antihypertensive regimens  Withdrawl syndromes – clonidine or beta antagonist  Drug-drug/drug-food interactions  Spinal cord disorders  Pheochromocytoma  Pregnancy  Collagen vascular disease
  • 8.
    Acute Target-Organ Damageand Clinical Manifestations Neurologic Cerebral infarction Hypertensive encephalopathy ICH or SAH Cardiovascular Acute pulmonary edema (LVF) Acute congestive failure (left/right ventricular failure) Acute coronary ischaemia (MI or unstable angina) Renal Acute kidney injury/failure Liver Liver enzymes elevations (HELLP syndrome) Ocular Retinal hemorrhage/exudate Vascular Eclampsia Aortic dissection
  • 10.
    BP Treatment goalsfor Hypertensive Emergency Goal Time BP Target First hour Reduce MAP by 25% (maintain goal DBP>100mmHg) Hours 2-6 SBP 160 mmHg and/or DBP 100-110 mmHg Hours 6-24 Maintain goals for hours 2-6 during first 24 hrs 24-48 hrs Outpatient BP goals according to the 2017 Guidelines for Management of High BP in adults.
  • 11.
    Treatment Goals  AcuteAortic Dissection  Medical management should be considered first line for most non-life threatening type B aortic dissection.  Goal heart rate – 60 beats/min within minutes of presentation.  Goal Blood Pressure – SBP < 120 mmHg and/or as low as clnically tolerated.
  • 12.
    Treatment Goals  AcuteIschemic Stroke  Adaptive response to maintain CPP to the brain.  Current Guidelines for BP reduction  Use of thrombolytic therapy  Other target organ damage ( aortic dissection, MI )  Severe elevated blood pressure SBP>220 mmHg & DBP>110 mmHg  For thrombolytic therapy initiation BP goal is less than 185/110 mmHg During therapy and subsequent 24 hrs BP goal is <180/105 mmHg  Other circumstances – BP goal is 15% (10-20%) reduction in MAP to allow maintainence of CPP
  • 14.
    Treatment Goals  AcuteHemorrhagic Stroke  Recent evidences suggest elevated BP during acute ICH are associated with hematoma expansion, neurologic deterioration and death.  BP goal – SBP < 160 mmHg over the first few hours is relatively safe.  ATACH-2 trial, patients were randomised with SBP target of < 140 mmHg or 140-180 mmHg acutely after ICH hypertensive emergency. Functional outcome did not differ.
  • 16.
    Acute Hypertensive Definationsin the Pregnant Patient Name BP Criteria Additional Criteria “Severe” acute hypertension SBP > 160 mmHg or DBP > 110 mmHg Preeclampsia SBP > 140 mmHg or DBP > 90 mmHg BP readings must occur on >2 occasions, > 4 hrs apart > 20 weeks gestation Either : Proteinuria Severe features Eclampsia Same as above New-onset grand mal seizures in a woman with no known seizure disorder HELLP syndrome With or without preeclampsia degree of BP elevation Evidence of the following Hemolysis Elevated lover enzymes Low platelet Hypertensive emergency BP > 240/140 mmHg
  • 17.
    Treatment Goals  Treatmentgoals differ in pregnant patients compared with general hypertensive crisis.  BP goal for Preeclampsia <160/110 mmHg – avoid abrupt decrease in blood pressure.  MAP should be decreased by 20-25% over the first few minutes to hours and blood pressure further decreased to the target of 160/110 mmHg or less over the subsequent hours.
  • 18.
    Treatment of Hypertensive Emergency No drug of choice.  Choice of medication depends on a risk-benefit analysis of each agent considering the.  Affected target organ on presentation  Pharmacokinetics & pharmacodynamics  Hemodynamic, adverse effect and BPV profile of the medication profile.  Extreme caution should be used with acute and profound lowering of BP Ischaemic complications.
  • 19.
    Medications Agent Dosing rangeOnset Duration Vasodilators Hydralazine IV Bolus: 10-20 mg IM : 10-40 mg q30 min PRN IV: 10 mins IM: 20 mins IV: 1-4 hours IM: 2-6 hours Nitroglycerine IV 5-200 mcg/min Titrate by 5-25 mcg/min q5-10 mins 2-5 mins 5-10 mins Sodium nitroprusside IV 0.25-10 mcg/kg/min Titrate by 0.1-0.2 mcg/min q5min seconds 1-2 mins CCB Clevidipine IV 1-6 mg/hr Titrate by 1-2 mg/hr q90s; max 32 mg/hr 1-4 min 5-15 min Nicardipine IV 5-15 mg/hr Titrate by 2.5 mg/hr q5-10 min 5-10 min 2-6 hours
  • 20.
    Agent Dosing rangeOnset Duration Beta Blockers Esmolol IV 25-300 mcg/kg/min Titrate by 25 mcg/kg/min q3-5 mins 1-2 mins 10-20 mins Labetalol IV bolus: 20 mg; may repeat doses of 20-80 mg q5-10 mins PRN IV 0.5-10 mg/min Titrate by 1-2 mg/min q2hr. 2-5 min; peak 5-15 mins 2-6 hr Upto 18 hr Metoprolol IV bolus: 5-15 mg q5-15 min PRN 5-20 min 2-6 hr ACEI Enalaprilat IV bolus: 1.25 mg q6hr Titrate no more than q12-24 hr: Max dose : 5 mg q6hr 15-30 min 12-24 hr a-Antagonist Phentolamine IV bolus: 1-5 mg PRN; Max 15 mg Seconds 15 min D1 Receptor Agonist
  • 21.
    Indications and SpecialConsiderations for Medications Used for Hypertensive Emergency Medication Indications Special Considerations Hydralazine Pregnancy Prolonged hypotension Risk of reflex tachycardia Headaches, lupus like syndrome Nitroglycerin Coronary ischaemia or infarction Acute LVF Pulmonary edema Tachyphylaxis Flushing, headache, erythema Venous greater than arterial dilator Sodium nitroprusside Most indications (excluding ICP elevations and coronary infarction/ischaemia) Liver failure – cyanide accumulation Renal failure – thiocyanate accumulation Toxicity with prolonged infusion Increases ICP Clevidipine Acute ischaemia or hemorrhagic Soy or egg allergy
  • 22.
    Medication Indications SpecialConsiderations Esmolol Aortic dissection Coronary ischaemia/infarction Contraindicated in acute decompensated heart failure Useful in tachyarrhythmias Labetalol Acute ischaemic or hg stroke Aortic dissection Coronary ischaemia/infarction Pregnancy Monotherapy in acute aortic dissection Contraindicated in acute decompensated heart failure Prolonged hypotension Metoprolol Aortic dissection Coronary ischaemia/infarction Contraindicated in acute decompensated heart failure Use in conjunction with arterial vasodilator Useful in tachyarrhythmias Enalaprilat Acute LVF Contraindicated in pregnancy Prolonged duration of action Phentolamine Cetecholamine excess e.g. pheochromocytoma Use in catecholamine-inducd HTN er Used for cocaine induced HTN crisis with BZDs Fenoldopam Most indications Caution with increased ICP or IOP
  • 24.
    Practice points • Determinethe presence or absence of target- organ damage. • Assessment • Screen for exceptions – stroke, pregnancy induced acute htn, aortic dissection- target goal development. • In general hypertensive emergencies the goal in the first 60 mins of treatment is reduce the MAP by25%. • Patient with exceptions have unique treatment goals leading to unique medication selection. • Goal of medication selection is to provide
  • 25.
    References  American collegeof cardiology – 2017 guideline for detection, evaluation and management of high blood pressure in adults.  American college of clinical pharmacology – ccsap2018 – hypertensive emergencies.  American college of obs&gynae (ACOG) – task force for htn in pregnancy.
  • 26.